The St. Jude researchers demonstrated that the Brca2 gene plays a dual role in the
developing nervous system, eliminating errors in the DNA of newly made copies of
chromosomes and suppressing the onset of the brain cancer medulloblastoma.
http://virtualtrials.com/pdf/sjmb96.pdf
Feasibility of Four Consecutive High-Dose Chemotherapy
Cycles With Stem-Cell Rescue for Patients With Newly
Diagnosed Medulloblastoma or Supratentorial Primitive
Neuroectodermal Tumor After Craniospinal Radiotherapy:
Results of a Collaborative Study
http://www.sciencedaily.com/releases/2008/06/080602114709.htm
Vaccine May Double Survival In Patients With Deadly Brain Tumors
Jun. 3, 2008 — A vaccine aimed at inducing immunity to the most common and deadly type of brain tumor may stave off recurrence and more than double survival in patients, according to a new study led by researchers in Duke's Preston Robert Tisch Brain Tumor Center.
http://www.sciencedaily.com/videos/2007/0910-unraveling_brain_tumors.htm
Unraveling Brain Tumors
Molecular Biologists Devise Strategy To Starve Brain Tumors
September 1, 2007 — Brain tumor researchers have found that brain tumors arise from cancer stem cells living within tiny protective areas formed by blood vessels in the brain. Killing those cells is a promising strategy to eliminate tumors and prevents them from re-growing. The researchers have found that drugs that block new blood vessel formation can destroy the protected areas and stop cancer from developing.
http://www.cancer.gov/ncicancerbulletin/NCI_Cancer_Bulletin_041508/page7
Herbal Therapy for Brain Cancer
Phase II Randomized Study of Adjuvant Boswellia Serrata and Standard Treatment Versus Standard Treatment Alone in Patients with Newly Diagnosed or Recurrent High-Grade Gliomas (CASE-CCF-7348). See the protocol summary at http://www.cancer.gov/clinicaltrials/CASE-CCF-7348.
Principal Investigator: Dr. Glen Stevens, Cleveland Clinic Foundation
